MASLD Substudy Sanyal et al., Nature Medicine (2024) Sanyal and colleagues conducted a prespecified phase 2a substudy of the original phase 2 obesity trial, evaluating retatrutide in participants with metabolic dysfunction-associated steatotic liver disease (MASLD)
It is worth checking these
To view a copy of this licence, visit About this article Cite this article Tan, X., Tsai, WL., Liang, Y
The impact of aging endothelial cells has been explored using mouse models, revealing that mice with accelerated senescence exhibit endothelial cellular dysfunction, impaired relaxation, and interstitial fibrosis, leading to HFpEF
Brand-name GLP-1s can cost over $12,000 per year out of pocket if you do not have insurance coverage, though recent manufacturer price cuts and discount programs have made GLP-1s more accessible for budget-conscious patients